M. Soikkelia,
K. Sievänena,
J. Peltonenb,
T. Kaasalainenb,
M. Timonenb,
P. Heinonena,
S. Rönkköc,
V.-P. Lehtoc,
J. S. Kavakkaa and
S. Heikkinen*a
aLaboratory of Organic Chemistry, Department of Chemistry, University of Helsinki, P.O. Box 55, FIN-00014 University of Helsinki, Finland. E-mail: Sami.Heikkinen@helsinki.fi
bHUS Helsinki Medical Imaging Center, P.O. Box 340, FIN-00029 HUS, Helsinki, Finland
cDepartment of Applied Physics, University of Eastern Finland, P.O. Box 1627, FIN-70211 Kuopio, Finland
First published on 27th January 2015
Two organic radical contrast agents, TEMPO-Glc and TEEPO-Glc, were synthesized and their stabilities and contrast enhancing properties were tested with in vitro NMR and MRI experiments. Owing to the glucose moieties in the prepared compounds, this study presents potential candidates for a tumor targeting fully organic contrast agents for MRI.
Contrast agents are commonly utilized in MRI studies to improve image contrast between diseased and healthy tissue. The majority of FDA-approved MRI contrast agents are based on Gd(III) complexes in addition to few superparamagnetic iron oxide (SPIO) agents.4 However, free transition metals, such as gadolinium and iron, are highly toxic in human body. Yet, the chelate structure of the contrast agent minimizes the risk of the release of the metal. Nevertheless, gadolinium based contrast agents have been shown to have a tendency to cause nephrogenic systemic fibrosis for patients with renal dysfunctions albeit nowadays the risk is extremely small.5 Although Gd(III) contrast agents are highly important and have good track record in tumor diagnostics, they are neither specifically targeting to malignant tissue nor they are actually cell permeable.6
Fully organic nitroxide radicals have been studied as potential contrast agents for MRI already in the 1980s.7 However, at that time the research ceased as the used nitroxides showed rapid reduction caused by natural reductants, like ascorbic acid, present in human body. As a result of reduction to corresponding hydroxylamine, the molecule loses its paramagnetic character and hence the ability to act as an MRI contrast agent. The stability of nitroxide radicals can be significantly improved, for instance, by delocalization of the unpaired electron or by steric hindrance. An example of the latter case is the replacement of the methyl substituents of the well-known stable nitroxide, TEMPO, by bulkier ethyl substituents leading to drastically increased resistance towards reduction.8,9
Quite recently, different nitroxides have been successfully utilized in MRI to study for instance the blood–brain barrier permeability,10 the tissue redox-state6,11 and the contrast enhancement.12,13 In addition, they have been applied in EPR imaging.14 However, to the best of our knowledge, currently there are no tumor targeting nitroxide contrast agents extensively studied or commercially available. These kinds of substances could possibly be achieved by attaching a radical moiety covalently to a targeting unit, analogically to PET and SPECT (single photon emission computed tomography) tracers.
In the current study, two different, potentially tumor targeting nitroxide radical contrast agents (Fig. 1) were synthesized. The nitroxide moieties TEMPO and TEEPO were chosen due to their reported good stability and also due to their relatively small size. Small size of the relaxation providing moiety could be considered as a benefit when attaching it to targeting unit. It could be hypothesized that too bulky radical moiety attached to a targeting unit could interfere the targeting properties as well as cell or blood–brain barrier permeability. Glucose (Glc) was selected as targeting unit based on its successful use in 18F-FDG PET. Both TEMPO-Glc and TEEPO-Glc were prepared in order to compare their stabilities, the latter assumed as the more stable one.
For the synthesis of product 1 the precursor (4-hydroxy-TEMPO) was readily available from commercial sources. In the case of product 2, the precursor 3 (4-hydroxy-TEEPO) was synthesized as described in literature15–17 with slight modifications. The glycosylations of the nitroxide precursors were performed according to Sato et al.18 using fluorinated glucose as the donor and boron trifluoride diethyl etherate as the promoter. The fluorinated glucose compound was prepared by using HF pyridine.19 The deacetylations of glycosylated nitroxides were performed either by standard Zemplén de-O-acetylation20 or conveniently by aqueous ammonia solution.21 In the glycosylation reaction of 4-hydroxy-TEEPO (3), the yield remained low due to further reduction of 4 to amine 5 (Scheme 1). The initial idea was to recycle amine 5 back to nitroxide 4 by oxidation. Disappointingly, neither hydrogen peroxide with sodium tungstate dihydrate as catalyst nor m-chloro-peroxybenzoic acid produced the desired nitroxide 4. As nitroxides with bulky side chains are resistant towards reduction, consequently the oxidation of the corresponding amine to nitroxide is difficult.
As linking nitroxides to glucose seems to have a slight effect on the stability of the compounds,22 radical stabilities of TEMPO-Glc and TEEPO-Glc were studied by T1-measurements as a function of time elapsed from the sample preparation. Human blood plasma was considered to be reasonable matrix to mimic in vivo conditions. The measurements were performed at 37 °C using 500 MHz NMR spectrometer. Both compounds were able to prevail several days in blood plasma without losing the capability to shorten water proton relaxation time T1. The results are shown in ESI (Table S1†).
More demanding stability tests in presence of a reductant were also performed. Samples with a radical concentration of 5 mM containing 10 μl of H2O in 600 μl of D2O were prepared. To the samples, a 10-fold excess of ascorbic acid was added and a set of rapid T1-measurements utilizing DESPOT-method (Driven Equilibrium Single Pulse Observation of T1)23 was immediately initiated. As a result, TEEPO-Glc showed superior stability towards reduction (Fig. 2). The relaxing properties of TEEPO-Glc remained effective at least 2–3 hours in 10-fold ascorbic acid excess, whereas TEMPO-Glc was completely reduced after 10 minutes. The results agreed well with the results by Paletta et al.,8 where the ethyl substituted nitroxide, 4-hydroxy-TEEPO, was found to be significantly more stable than the methyl substituted counterpart, 4-hydroxy-TEMPO.
The water proton T1-relaxation time reducing properties of TEEPO-Glc and TEMPO-Glc in blood plasma vs. radical concentration were studied using 1H NMR spectroscopy at 11.7 T (1H-frequency 500 MHz, 37 °C). The 11.7 T results presented in Fig. 3 show, that both radicals enhance water R1-relaxation rate (R1 = 1/T1) in blood plasma. As expected, the relaxation rates increase linearly as a function of radical concentration. Linearity suggests the absence of aggregation in the concentration range studied.12
MRI tests were performed to study the effect of the contrast agents to the relaxation times of water in blood plasma at a clinical MRI magnetic field strength of 1.5 T. Concentrations of 0.2, 0.5, 1, 2, 5, 10 and 16 mM were selected for the phantom. As a reference, three samples of clinically used contrast agent, gadopentetate dimeglumine, were also included. As the relaxation is more effective with agents containing Gd(III) due to the total of seven unpaired electrons in contrast to the one single unpaired electron in the prepared radicals, the concentrations of gadolinium samples were significantly smaller, 0.01, 0.1 and 1 mM. The composition of the phantom, T1-weighted gradient echo MRI, the T1- and T2-maps of the phantoms as well as the T1- and T2-relaxation times at different concentrations are illustrated in Fig. 4. In order to emphasize the differences between different concentrations, the T1- and T2-maps are presented in color. It appears, that when the radical concentration exceeds 0.5 mM, the resulting intensity difference in the relaxation time images between undoped and doped vial starts to be visually detectable and at concentration of 1.0 mM the difference is very clear for both T1- and T2-maps. This can also be seen in T1-weighted gradient echo image, especially after 1 mM. This is even more prominent when color scale is used (ESI, Fig. S1†). The obtained results suggest the potentiality of the compound as MRI contrast agent, since similar in vivo concentrations have been previously detected for other radical compounds.24 Furthermore, although the relaxivity of the radical is significantly lower than that of Gd(III)-based contrast agents, it may be hypothesized that the presence of the targeting group might ensure a sufficient radical concentration in the target tissue and thus produce a proper contrast without extreme dosing.
Also, preliminary elucidation of cytotoxicity effects of TEEPO-Glc was performed using HeLa cells. Different concentrations of TEEPO-Glc (0.2, 1 and 10 mM) were incubated for 1, 6 and 24 h and their cytotoxicity was studied using CellTiter-Glo® assay (Fig. 5). The assay is based on quantitation of ATP and the amount of ATP is directly proportional to the number of living cells. The results of CellTiter-Glo® assay showed that the very high concentration of TEEPO-Glc (10 mM) and with long incubation time (24 h) decreased significantly cellular viability (p < 0.05) when compared to unexposed controls. However, toxicity was not observed at shorter incubation times (1 h and 6 h). And furthermore, all other tested concentrations of TEEPO-Glc (0.2 mM and 1 mM) with time points at 1, 6 or 24 h did not affect the viability of HeLa cells.
Footnote |
† Electronic supplementary information (ESI) available: Synthesis and characterization of the compounds, description of NMR/MRI parameters used in stability and relaxivity studies and the method for the cell viability study are described. See DOI: 10.1039/c4ra11455h |
This journal is © The Royal Society of Chemistry 2015 |